We are interested in how persistent inflammation in the brain influences neurocognitive function in people with HIV/AIDS. Our current emphasis is on its effect on synaptic protein turnover and dopaminergic synaptic transmission. We are a national resource for HIV/AIDS neuropathology and a founding center of the National NeuroAIDS Tissue Consortium. We also participate in the CHARTER study, which is a multi-site cross-sectional and longitudinal study of dementia in HIV-infected people. Research in the laboratory is focused on HIV-related neurodegeneration. One project is elucidating how reducing HIV loads with highly active antiretroviral therapy influences painful peripheral neuropathy. Another project is exploring how neuronal protein turnover through the ubiquitin-proteasome system is abnormal in people with HIV dementia. Our basic approach is to perform neurochemical analysis of banked human brain specimens that we collected from people with HIV infection. Dr. Gelman is the founder and Principal Investigator of the Texas NeuroAIDS Research Center with clinics in Galveston, Houston and Dallas. The Center is one of four HIV brain repositories of the National NeuroAIDS Tissue Consortium (NNTC). Subjects are followed prospectively and CNS and PNS specimens and data are banked at autopsy. Neurological, neurocognitive and drug use documentation information is stored in a database for use by researchers. Specimens and data are distributed to investigators around the world.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
GCC Cluster for Alcohol and Addiction Research
Gulf Coast Cluster for Translational Addiction Science
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.